Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, has announ ...
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, has announced the closing of a $37 million Series A financing led by Kineticos Ventures. Proceeds from th ...
Read more